Is chemotherapy-induced peripheral neuropathy driving demand for novel neuroprotective therapies in Indian oncology?
The rapid expansion of oncology treatment facilities and increased survival rates among cancer patients across India are highlighting the challenge of chemotherapy-induced peripheral neuropathy (CIPN). Detailed analysis within the India Neuropathic Pain Market report reveals that neurotoxic chemotherapy agents—such as platinum-based compounds, taxanes, and vinca alkaloids—frequently...
0 Comments 0 Shares 305 Views 0 Reviews